Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests.

Abstract:

:Conventional coagulation tests might be inadequate to explore mechanisms regulating thrombin generation in neonates, because they do not allow full activation of the reduced levels of protein C. Therefore, they do not reflect the action of pro- and anti-coagulants as does the endogenous thrombin potential assessed in the presence of thrombomodulin. Endogenous thrombin potential measured without thrombomodulin was greater than the lower-limit of the adult reference interval in 30% of 109 full-term and 49% of 55 pre-term neonates, a finding consistent with the reduced levels of procoagulants in this setting. When the test was modified adding thrombomodulin, endogenous thrombin potential reverted into the adult reference interval in 97% and 100% full-term and pre-term neonates. In conclusion, the coagulation balance in neonates is restored by the concomitant reduction of pro- and anticoagulants. The restored balance can be shown in vitro by the endogenous thrombin potential test that includes thrombomodulin, but not by conventional coagulation tests.

journal_name

Haematologica

journal_title

Haematologica

authors

Tripodi A,Ramenghi LA,Chantarangkul V,De Carli A,Clerici M,Groppo M,Mosca F,Mannucci PM

doi

10.3324/haematol.12566

subject

Has Abstract

pub_date

2008-08-01 00:00:00

pages

1256-9

issue

8

eissn

0390-6078

issn

1592-8721

pii

haematol.12566

journal_volume

93

pub_type

杂志文章
  • Aerobic glycolysis fuels platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents.

    abstract::Platelets are critical to arterial thrombosis, which underlies myocardial infarction and stroke. Activated platelets, regardless of the nature of their stimulus, initiate energy-intensive processes that sustain thrombus, while adapting to potential adversities of hypoxia and nutrient deprivation within the densely pac...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2018.205724

    authors: Kulkarni PP,Tiwari A,Singh N,Gautam D,Sonkar VK,Agarwal V,Dash D

    更新日期:2019-04-01 00:00:00

  • Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial.

    abstract:BACKGROUND:There is variability in the outcome of patients with chronic lymphocytic leukemia with apparently the same stage of disease. Identifying genetic variants that influence patients' outcome and response to treatment may provide important insights into the biology of the disease. DESIGN AND METHODS:We investiga...

    journal_title:Haematologica

    pub_type: 杂志文章,随机对照试验

    doi:10.3324/haematol.2011.043471

    authors: Wade R,Di Bernardo MC,Richards S,Rossi D,Crowther-Swanepoel D,Gaidano G,Oscier DG,Catovsky D,Houlston RS

    更新日期:2011-10-01 00:00:00

  • Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.

    abstract:BACKGROUND AND OBJECTIVES:Dendritic cells (DC) pulsed with multiple myeloma (MM) patient-specific idiotype (Id) protein can induce MM-specific T-cell responses. DESIGN AND METHODS:We established serum-free culture conditions to generate monocyte-derived DC for clinical use to circumvent anti-xenogenic immune responses...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:

    authors: Reichardt VL,Milazzo C,Brugger W,Einsele H,Kanz L,Brossart P

    更新日期:2003-10-01 00:00:00

  • Genotypic heterogeneity may explain phenotypic variations in inherited factor VII deficiency.

    abstract::Inherited factor VIl (FVII) deficiency is a rare autosomal recessive coagulation disorder characterized by a wide genet-ic heterogeneity and a poor relationship between FVII activity (FVII:C) levels and severity of the hemorrhagic diathesis. Given both the rarity and the heterogeneity of this disorder,genotype-phenoty...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Giansily-Blaizot M,Aguilar-Martinez P,Schved JF

    更新日期:2002-03-01 00:00:00

  • Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma.

    abstract::Relapsed/refractory multiple myeloma represents a major challenge in multiple myeloma therapy. For patients with relapsed/refractory multiple myeloma, we developed a treatment schema of metronomically scheduled drug therapy. We identified 186 patients who had been treated with metronomic therapy between March 2004 and...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.085183

    authors: Papanikolaou X,Szymonifka J,Rosenthal A,Heuck CJ,Mitchell A,Johann D Jr,Keller J,Waheed S,Usmani SZ,Van Rhee F,Bailey C,Petty N,Hoering A,Crowley J,Barlogie B

    更新日期:2013-07-01 00:00:00

  • Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.

    abstract:BACKGROUND AND OBJECTIVES:Whether human mesenchymal stem cells (MSC) can be transplanted is controversial and their presence in peripheral blood is not fully accepted. In the present study we have analyzed whether, within the allogeneic transplantation setting, MSC are of host or donor origin. DESIGN AND METHODS:Bone ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Villaron EM,Almeida J,López-Holgado N,Alcoceba M,Sánchez-Abarca LI,Sanchez-Guijo FM,Alberca M,Pérez-Simon JA,San Miguel JF,Del Cañizo MC

    更新日期:2004-12-01 00:00:00

  • Placental/umbilical cord blood transplantation.

    abstract::In this article we summarize the clinical outcome of unrelated placental/umbilical cord blood (CB) transplantation, discuss the biological characteristics of CB hematopoietic progenitor/stem cells (HPC) and balance the relative advantages and disadvantages of this therapy as compared with transplantation of other HPC ...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:

    authors: Sirchia G,Rebulla P

    更新日期:1999-08-01 00:00:00

  • Treatment of acute graft versus host disease with low dose-alternate day anti-thymocyte globulin.

    abstract:BACKGROUND AND OBJECTIVES:The efficacy of antithymocyte globulin (ATG) in the treatment of graft-versus-host disease (GvHD) is controversial. In the present study we report on the use of low dose ATG (thymoglobuline, Sangstat) and steroids in 28 patients with moderate to severe acute GvHD. DESIGN AND METHODS:Fifteen p...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Graziani F,Van Lint MT,Dominietto A,Raiola AM,Di Grazia C,Lamparelli T,Gualandi F,Bregante S,Fiorone M,Bruno B,Bacigalupo A

    更新日期:2002-09-01 00:00:00

  • Dendritic cells: specialized antigen presenting cells.

    abstract::Renewing interest in cancer immunotherapy reflects the excellent results that have been obtained in animal models and the promising results in early clinical trails with dendritic cell (DC) based approaches. The central role that DCs play in the initiation of an immune response raises the possibility of using them to ...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:

    authors: Di Nicola M,Lemoli RM

    更新日期:2000-02-01 00:00:00

  • Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.

    abstract:BACKGROUND:Routine electrophoretic analysis fails to detect a monoclonal component (MC) in a considerable portion of AL amyloidosis patients. We investigated whether the combination of immunofixation (IF) on agarose gel electrophoresis and bone marrow plasma cell (BMPC) light chain kappa/lambda ratio analysis could con...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Perfetti V,Garini P,Vignarelli MC,Marinone MG,Zorzoli I,Merlini G

    更新日期:1995-09-01 00:00:00

  • STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.

    abstract::Systemic anaplastic large cell lymphoma is a category of T-cell non-Hodgkin's lymphoma which can be further subdivided into two distinct entities (ALK(+) and ALK(-)) based on the presence or absence of ALK gene rearrangements. Among several pathways triggered by ALK signaling, constitutive activation of STAT3 is stric...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.088286

    authors: Spaccarotella E,Pellegrino E,Ferracin M,Ferreri C,Cuccuru G,Liu C,Iqbal J,Cantarella D,Taulli R,Provero P,Di Cunto F,Medico E,Negrini M,Chan WC,Inghirami G,Piva R

    更新日期:2014-01-01 00:00:00

  • A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.

    abstract::The objective of this study was to create a bioclinical model, based on clinical and molecular predictors of event-free and overall survival for relapsed/refractory diffuse large B-cell lymphoma patients treated on the Canadian Cancer Trials Group (CCTG) LY12 prospective study. In 91 cases, sufficient histologic mater...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:10.3324/haematol.2017.179309

    authors: Bosch M,Akhter A,Chen BE,Mansoor A,Lebrun D,Good D,Crump M,Shepherd L,Scott DW,Stewart DA

    更新日期:2018-02-01 00:00:00

  • IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study.

    abstract::Patients with chronic lymphocytic leukemia and unmutated immunoglobulin heavy-chain variable region gene (IGHV) have inferior survival from time of treatment in clinical studies. We assessed real-world outcomes based on mutational status and treatment regimen in a nationwide population-based cohort, comprising all 4,1...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2019.220194

    authors: Rotbain EC,Frederiksen H,Hjalgrim H,Rostgaard K,Egholm GJ,Zahedi B,Poulsen CB,Enggard L,da Cunha-Bang C,Niemann CU

    更新日期:2020-06-01 00:00:00

  • In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures.

    abstract:BACKGROUND AND OBJECTIVES:Imatinib induces complete cytogenetic responses (CCR) in the majority of patients with chronic myeloid leukemia (CML) in chronic phase (CP). However, a subgroup of patients is refractory at the cytogenetic level. Clinically, it would be advantageous to identify such patients a priori, since th...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Crossman LC,Mori M,Hsieh YC,Lange T,Paschka P,Harrington CA,Krohn K,Niederwieser DW,Hehlmann R,Hochhaus A,Druker BJ,Deininger MW

    更新日期:2005-04-01 00:00:00

  • Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response.

    abstract::Our objective was to determine whether the goal of high-dose therapy should be a partial hematologic response or a complete response. We analyzed 282 consecutive stem cell transplant patients. A partial hematologic response was achieved in 108 patients (38%), and 93 (33%) achieved a complete hematologic response. Surv...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.11413

    authors: Gertz MA,Lacy MQ,Dispenzieri A,Hayman SR,Kumar SK,Leung N,Gastineau DA

    更新日期:2007-10-01 00:00:00

  • Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.

    abstract:BACKGROUND AND OBJECTIVES:The aim of this study was to evaluate the tolerability and effectiveness of a non-myeloablative conditioning regimen followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune diseases. DESIGN AND METHODS:From 1996 patients with severe autoimmune disease no...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Rabusin M,Andolina M,Maximova N,Lepore L,Parco S,Tuveri G,Jankovic G

    更新日期:2000-11-01 00:00:00

  • Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells.

    abstract::Chronic lymphocytic leukemia is an incurable B-cell malignancy that is associated with tumor cell-mediated T-cell dysfunction. It therefore represents a challenging disease for T-cell immunotherapeutics. The CD19/CD3 bi-specific antibody construct blinatumomab (AMG103 or MT103) has been tested clinically in non-Hodgki...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2012.082248

    authors: Wong R,Pepper C,Brennan P,Nagorsen D,Man S,Fegan C

    更新日期:2013-12-01 00:00:00

  • Structural and cellular mechanisms of peptidyl-prolyl isomerase Pin1-mediated enhancement of Tissue Factor gene expression, protein half-life, and pro-coagulant activity.

    abstract::Tissue Factor is a cell-surface glycoprotein expressed in various cells of the vasculature and is the principal regulator of the blood coagulation cascade and hemostasis. Notably, aberrant expression of Tissue Factor is associated with cardiovascular pathologies such as atherosclerosis and thrombosis. Here, we sought ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2017.183087

    authors: Kurakula K,Koenis DS,Herzik MA Jr,Liu Y,Craft JW Jr,van Loenen PB,Vos M,Tran MK,Versteeg HH,Goumans MTH,Ruf W,de Vries CJM,Şen M

    更新日期:2018-06-01 00:00:00

  • Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.

    abstract:BACKGROUND AND OBJECTIVES:Detection of minimal residual disease (MRD) by multiparameter flow cytometry is an emerging prognostic factor in patients with acute myeloid leukemia (AML). The present analysis aimed at improving the applicability of this approach to more patients with AML. DESIGN AND METHODS:Bone marrow sam...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Kern W,Danhauser-Riedl S,Ratei R,Schnittger S,Schoch C,Kolb HJ,Ludwig WD,Hiddemann W,Haferlach T

    更新日期:2003-06-01 00:00:00

  • Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN. However, it is not clear whether NOTCH1 mutations associate with decreased PTEN expression in primary T-ALL. Here, we compared patients with or wi...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2009.011999

    authors: Silva A,Jotta PY,Silveira AB,Ribeiro D,Brandalise SR,Yunes JA,Barata JT

    更新日期:2010-04-01 00:00:00

  • Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic state.

    abstract::In contrast to well-established hierarchical concepts of tumor stem cells, leukemia-initiating cells in B-cell precursor acute lymphoblastic leukemia have not yet been phenotypically identified. Different subpopulations, as defined by surface markers, have shown equal abilities to reconstitute leukemia upon transplant...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2017.167502

    authors: Trentin L,Queudeville M,Eckhoff SM,Hasan N,Münch V,Boldrin E,Seyfried F,Enzenmüller S,Debatin KM,Meyer LH

    更新日期:2018-06-01 00:00:00

  • A case of adult T cell leukemia and lymphoma in an Italian woman showing different malignant clones in tumor mass and in blood.

    abstract::HTLV-1 infections and their associated diseases are very rare in Italy, as well as in most parts of Europe, occurring prevalently in subjects related to endemic areas. The HTLV-1-associated leukemia/lymphoma, ATLL, is a very aggressive T-cell non-Hodgkin's lymphoma which can be difficult to recognize in non-endemic ar...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Menin C,Bulian P,Filippi F,Buttarello M,Casado C,Lopez-Galindez C,De Rossi A,Chieco-Bianchi L,Del Mistro A

    更新日期:2003-07-01 00:00:00

  • Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.

    abstract::Drug resistance impedes the long-term effect of targeted therapies in acute myeloid leukemia (AML), necessitating the identification of mechanisms underlying resistance. Approximately 25% of AML patients carry FLT3 mutations and develop post-treatment insensitivity to FLT3 inhibitors, including sorafenib. Using a geno...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2020.257964

    authors: Damnernsawad A,Bottomly D,Kurtz SE,Eide CA,McWeeney SK,Tyner JW,Nechiporuk T

    更新日期:2020-12-30 00:00:00

  • A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity.

    abstract::Sixteen patients with stage III multiple myeloma (MM) and a median age of 51 years were treated with autografting followed by reduced intensity conditioning allotransplantation (RICT). Nine patients are alive in remission at a median of 30 months after their transplants, one patient is alive in relapse and 6 patients ...

    journal_title:Haematologica

    pub_type: 临床试验,信件

    doi:

    authors: Carella AM,Beltrami G,Corsetti MT,Scalzulli P,Carella AM Jr,Musto P

    更新日期:2004-12-01 00:00:00

  • Estimation of bone marrow cellularity by means of vertebral magnetic resonance.

    abstract:BACKGROUND AND OBJECTIVE:A magnetic resonance (MR) signal shows an inverse correlation with bone marrow cellularity. In this study, we investigated the possibility of estimating the degree of bone marrow cellularity by means of this non-invasive technique. METHODS:In 25 patients with different hematological disorders ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Rozman M,Mercader JM,Aguilar JL,Montserrat E,Rozman C

    更新日期:1997-03-01 00:00:00

  • Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.

    abstract:BACKGROUND AND OBJECTIVE:Hepatocyte growth factor (HGF) is known to augment the effects of stem cell factor, interleukin-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), erythropoetin, and granulocyte colony-stimulating factor, all of which are involved in hematopoiesis. HGF is also known to have a role in...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Ovali E,Ratip S,Kibaroglu A,Tekelioglu Y,Cetiner M,Karti S,Aydin F,Bayik M,Akoglu T

    更新日期:2000-05-01 00:00:00

  • The association of cyclophosphamide and dexamethasone in advanced refractory multiple myeloma patients.

    abstract::VAD is the most active regimen in refractory myeloma patients; however, the role of vincristine and doxorubicin remains unclear. Relatively high doses of cyclophosphamide (3.6 g/sqm) increased the response rate and survival in resistant MM. Cyclophosphamide and dexamethasone were administered to 28 patients with advan...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Celesti L,Clavio M,Poggi A,Casciaro S,Vallebella E,Gobbi M

    更新日期:1997-05-01 00:00:00

  • Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.

    abstract::Imatinib mesylate is a tyrosine kinase inhibitor used as first line treatment in chronic myeloid leukemia and gastrointestinal stromal tumor patients. Although several in vitro and animal studies demonstrated that imatinib affects immune response, few immune alterations are described in humans. We retrospectively stud...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.12642

    authors: Santachiara R,Maffei R,Martinelli S,Arcari A,Piacentini F,Trabacchi E,Alfieri P,Ferrari A,Leonardi G,Luppi G,Longo G,Vallisa D,Marasca R,Torelli G

    更新日期:2008-08-01 00:00:00

  • Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.

    abstract::Signaling through the αβT cell receptor (TCR) is a crucial determinant of T-cell fate and can induce two opposite outcomes during thymocyte development: cell death or survival and differentiation. To date, the role played by T-cell receptor in the oncogenic transformation of developing T cells remains unclear. Here we...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2018.188359

    authors: Gon S,Loosveld M,Crouzet T,Potier D,Bonnet M,Morin SO,Michel G,Vey N,Nunès JA,Malissen B,Roncagalli R,Nadel B,Payet-Bornet D

    更新日期:2018-06-01 00:00:00

  • Immobilized fibrinogen activates human platelets through glycoprotein VI.

    abstract::Glycoprotein VI, a major platelet activation receptor for collagen and fibrin, is considered a particularly promising, safe antithrombotic target. In this study, we show that human glycoprotein VI signals upon platelet adhesion to fibrinogen. Full spreading of human platelets on fibrinogen was abolished in platelets f...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2017.182972

    authors: Mangin PH,Onselaer MB,Receveur N,Le Lay N,Hardy AT,Wilson C,Sanchez X,Loyau S,Dupuis A,Babar AK,Miller JL,Philippou H,Hughes CE,Herr AB,Ariëns RA,Mezzano D,Jandrot-Perrus M,Gachet C,Watson SP

    更新日期:2018-05-01 00:00:00